Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 8, 2007 - Issue 15
Submit an article Journal homepage
259
Views
13
CrossRef citations to date
0
Altmetric
Drug Evaluation

Aralast: an α1-protease inhibitor for the treatment of α-antitrypsin deficiency

Nicholas M Mordwinkin HIV Pharmacotherapy Fellow, University of Southern California School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90089, USA [email protected]
, PharmD &
Stan G Louie Associate Professor, University of Southern California School of Pharmacy, 1985 Zonal Avenue, Los Angeles, CA 90089, USA [email protected]
Pages 2609-2614 | Published online: 11 Oct 2007

Bibliography

  • PAUWELS RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. (2001) 163(5):1256-1276.
  • STOLLER JK, Aboussouan LS: α1-Antitrypsin deficiency. Lancet (2005). 365(9478):2225-2236.
  • JANOFF A: Elastases and emphysema. Current assessment of the protease–antiprotease hypothesis. Am. Rev. Respir. Dis. (1985) 132(2):417-433.
  • DE SERRES FJ: Worldwide racial and ethnic distribution of α1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest (2002) 122(5):1818-1829.
  • A registry of patients with severe deficiency of α1-antitrypsin. Design and methods. The α1-antitrypsin deficiency registry study group. Chest (1994) 106(4):1223-1232.
  • SHIN MS, HO KJ: Bronchiectasis in patients with α1-antitrypsin deficiency. A rare occurrence? Chest (1993) 104(5):1384-1386.
  • GADEK JE, Fells GA, Zimmerman RL, Rennard SI, Crystal RG: Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema. J. Clin. Invest. (1981) 68(4):889-898.
  • GADEK JE, Klein HG, Holland PV, Crystal RG: Replacement therapy of α1-antitrypsin deficiency. Reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects. J. Clin. Invest. (1981) 68(5):1158-1165.
  • BRANTLY M, NUKIWA T, CRYSTAL RG: Molecular basis of α-1-antitrypsin deficiency. Am. J. Med. (1988) 84(6A):13-31.
  • DEMEO DL, SILVERMAN EK: α1-antitrypsin deficiency. 2: genetic aspects of α(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax (2004) 59(3):259-264.
  • CUVELIER A, Muir JF, Hellot MF et al.: Distribution of α(1)-antitrypsin alleles in patients with bronchiectasis. Chest (2000) 117(2):415-419.
  • MAHADEVA R, Chang WS, Dafforn TR et al.: Heteropolymerization of S, I, and Z α1-antitrypsin and liver cirrhosis. J. Clin. Invest. (1999) 103(7):999-1006.
  • EDMONDS BK, HODGE JA, RIETSCHEL RL: α1-antitrypsin deficiency-associated panniculitis: case report and review of the literature. Pediatr. Dermatol. (1991) 8(4):296-299.
  • STOLLER JK, Smith P, Yang P, Spray J: Physical and social impact of α1-antitrypsin deficiency: results of a survey. Cleve. Clin. J. Med. (1994) 61(6):461-467.
  • CAMPOS MA, Wanner A, Zhang G, Sandhaus RA: Trends in the diagnosis of symptomatic patients with α1-antitrypsin deficiency between 1968 and 2003. Chest (2005) 128(3):1179-1186.
  • STOLLER JK, Sandhaus RA, Turino G, Dickson R, Rodgers K, Strange C: Delay in diagnosis of α1-antitrypsin deficiency: a continuing problem. Chest (2005) 128(4):1989-1994.
  • STOLLER JK, Tomashefski J Jr, Crystal RG et al.: Mortality in individuals with severe deficiency of α1-antitrypsin: findings from the National heart, lung, and blood institute registry. Chest (2005) 127(4):1196-1204.
  • HUBBARD RC, Sellers S, Czerski D, Stephens L, Crystal RG: Biochemical efficacy and safety of monthly augmentation therapy for α1-antitrypsin deficiency. JAMA (1988) 260(9):1259-1264.
  • BARKER AF, Iwata-Morgan I, Oveson L, Roussel R: Pharmacokinetic study of α1-antitrypsin infusion in α1-antitrypsin deficiency. Chest (1997) 112(3):607-613.
  • PACKAGE INSERT: Aralast α1-proteinase inhibitor (human). Westlake Village: Baxter Healthcare Corporation (2007).
  • LOUIE SG, SCLAR DA, GILL MA: Aralast: a new α1-protease inhibitor for treatment of α-antitrypsin deficiency. Ann. Pharmacother. (2005) 39(11):1861-1869.
  • STOLLER JK, Rouhani F, Brantly M et al.: Biochemical efficacy and safety of a new pooled human plasma α(1)-antitrypsin, respitin. Chest (2002) 122(1):66-74.
  • SEERSHOLM N, Wencker M, Banik N et al.: Does α1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary α1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) α1-AT study group. Eur. Respir. J. (1997) 10(10):2260-2263.
  • WENCKER M, Fuhrmann B, Banik N, Konietzko N: Longitudinal follow-up of patients with α(1)-protease inhibitor deficiency before and during therapy with IV α(1)-protease inhibitor. Chest (2001) 119(3):737-744.
  • HUBBARD RC, Brantly ML, Sellers SE, Mitchell ME, Crystal RG: Anti-neutrophil-elastase defenses of the lower respiratory tract in α1-antitrypsin deficiency directly augmented with an aerosol of α1-antitrypsin. Ann. Intern. Med. (1989) 111(3):206-212.
  • HUBBARD RC, McElvaney NG, Sellers SE et al.: Recombinant DNA-produced α1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with α1-antitrypsin deficiency. J. Clin. Invest. (1989) 84(4):1349-1354.
  • ROSENFELD MA, Siegfried W, Yoshimura K et al.: Adenovirus-mediated transfer of a recombinant α1-antitrypsin gene to the lung epithelium in vivo. Science (1991) 252(5004):431-434.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.